Alexander Bott

First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA Trial

A. Rosenwald, M. Ziepert, W. Klapper, 2022, HemaSphere.